Publications in collaboration with researchers from Charles University in Prague (2)

2019

  1. Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

    European Journal of Cancer, Vol. 107, pp. 186-195

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine